Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review Journal Articles

Overview
Research
Identity
Additional Document Info
View All

abstract

Key Points New data plus a literature review documented new thrombosis in only 1 (2.2%) of 46 patients with acute HIT who were treated with rivaroxaban. The literature review found similarly favorable results, albeit with fewer patients, when apixaban and dabigatran were used to treat acute HIT.

authors

status

published

publication date

August 31, 2017

has subject area

1102 Cardiorespiratory Medicine and Haematology (FoR)
1103 Clinical Sciences (FoR)
1114 Paediatrics and Reproductive Medicine (FoR)
Acute Disease (MeSH)
Administration, Oral (MeSH)
Aged (MeSH)
Aged, 80 and over (MeSH)
Anticoagulants (MeSH)
Female (MeSH)
Fondaparinux (MeSH)
Heparin (MeSH)
Humans (MeSH)
Immunology (Science Metrix)
Male (MeSH)
Middle Aged (MeSH)
Ontario (MeSH)
Polysaccharides (MeSH)
Rivaroxaban (MeSH)
Thrombocytopenia (MeSH)
Treatment Outcome (MeSH)

published in

Blood Journal